[Restenosis following coronary dilatation].
Restenoses following successful coronary angioplasty occur in about 30 to 35% and are the most important limitative factor of this method. The etiology of restenosis is multifactorial. A beneficial effect in reducing restenosis could not be demonstrated for any drug in the clinical stage. First results with the administration of n-3-fatty acids revealed a favourable influence on recurrence. Further on, the value of newer interventional methods on restenosis rate is also uncertain. Thus, the problem of restenosis remains unresolved.
I. Medizinischen Abteilung, a.ö. Krankenhauses der Stadt Linz.
F
F
Leisch
D015906:Angioplasty, Balloon, Coronary; D003131:Combined Modality Therapy; D003327:Coronary Disease / Q000188:drug therapy / Q000628:therapy*; D006801:Humans; D012008:Recurrence
Restenosierung nach Koronardilatation.